SEC Form 4 · accession 0001312326-15-000001
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas W Baxter
Director
Period of report
Jul 8, 2011
Accepted (ET)
Sep 24, 2015 · 7:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.25 | Sep 21, 2015 | E | 200,000 | D | Mar 21, 2014 | Sep 21, 2015 | Common Shares | 200,000 | 0 | D |
Explanation of responses
- F1Warrants Expired